3L. Thomas Vlasveld,Jos H. Beynen,Willem Boogerd,Willem W. Bokkel Huinink,Sjoerd Rodenhuis. Complete remission of brain metastases of ovarian cancer following high-dose carboplatin: a case report and pharmacokinetic study[J] 1990,Cancer Chemotherapy and Pharmacology(5):382～383
4Yasutsuna Sasaki,Tomohide Tamura,Kenji Eguchi,Tetsu Shinkai,Yasuhiro Fujiwara,Masaaki Fukuda,Yuichiro Ohe,Masami Bungo,Naoya Horichi,Shigeki Niimi,Koichi Minato,Kazuhiko Nakagawa. Pharmacokinetics of (glycolato-0,0′)-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin[J] 1989,Cancer Chemotherapy and Pharmacology(4):243～246
5Robert C. Gaver,Nicoletta Colombo,Michael D. Green,Alice M. George,George Deeb,Alan D. Morris,Renzo M. Canetta,James L. Speyer,Raymond H. Farmen,Franco M. Muggia. The disposition of carboplatin in ovarian cancer patients[J] 1988,Cancer Chemotherapy and Pharmacology(3):263～270
6Sarah E. Dible,Zahid H. Siddik,Kenneth R. Harrap. The comparative tissues distribution of platinum and 14C in mice receiving 14C-labelled carboplatin[J] 1988,Cancer Chemotherapy and Pharmacology(1):11～16
7F. Elferink,W. J. F. Vijgh,I. Klein,W. W. Bokkel Huinink,R. Dubbelman,J. G. McVie. Pharmacokinetics of carboplatin after intraperitoneal administration[J] 1988,Cancer Chemotherapy and Pharmacology(1):57～60
8Robert C. Gaver,Alice M. George,George Deeb. In vitro stability, plasma protein binding and blood cell partitioning of 14C-carboplatin[J] 1987,Cancer Chemotherapy and Pharmacology(4):271～276
9Phillip A. Reece,James F. Bishop,Ian N. Olver,Irene Stafford,Brian L. Hillocat,George Morstyn. Pharmacokinetics of unchanged carboplatin (CBDCA) in patients with small cell lung carcinoma[J] 1987,Cancer Chemotherapy and Pharmacology(4):326～330
10Robert C. Gaver,George Deeb. High-performance liquid chromatographic procedures for the analysis of carboplatin in human plasma and urine[J] 1986,Cancer Chemotherapy and Pharmacology(3):201～206
